Nxnem1(IMPC)J
|
JAX
|
Gross Morphology Embryo E18.5 / Edema
|
HET
|
6f:10m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Gross Morphology Embryo E18.5 / Edema
|
HET
|
10f:9m
|
Supplied as data
|
1.00
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Gross Morphology Embryo E18.5 / Edema
|
HOM
|
8f:5m
|
Supplied as data
|
1.00
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Gross Morphology Embryo E18.5 / Edema
|
HET
|
8f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxnem1(IMPC)J
|
JAX
|
Gross Morphology Embryo E18.5 / Edema
|
HOM
|
1f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Gross Morphology Embryo E18.5 / Edema
|
HOM
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Gross Morphology Embryo E18.5 / Edema
|
HOM
|
13f:5m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Gross Morphology Embryo E18.5 / Edema
|
HOM
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Gross Morphology Embryo E18.5 / Edema
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0133
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.133
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.241
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.448
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.518
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.519
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.541
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.616
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.719
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.754
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
6f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.845
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.870
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Lipase
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.385
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Creatinine
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Clinical Chemistry / Creatinine
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Creatinine
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0128
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / Creatinine
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.178
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Clinical Chemistry / Creatinine
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.257
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatinine
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.440
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Clinical Chemistry / Creatinine
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.634
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Creatinine
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.681
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.700
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Creatinine
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.708
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Creatinine
|
HET
|
6f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.767
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Creatinine
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.792
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Creatinine
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.809
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Plasma Chemistry / Total cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.713
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Fructosamine
|
HET
|
6f:5m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0542
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.238
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Fructosamine
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.625
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Plasma Chemistry / Triglycerides
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.461
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Glucose
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Glucose
|
HET
|
5f:5m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Glucose
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
2.50×10-05
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.000246
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00574
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0170
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0485
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0729
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
6f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0978
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0980
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.194
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.281
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.420
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.439
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Urea
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Urea
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Urea
|
HET
|
5f:5m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Sodium
|
HET
|
5f:5m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Sodium
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Sodium
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Potassium
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Potassium
|
HET
|
5f:5m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Potassium
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.223
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Alpha-amylase
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.597
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Alpha-amylase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.796
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alpha-amylase
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.991
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / Iron
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0148
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Iron
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0247
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Clinical Chemistry / Iron
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.270
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Iron
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.460
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Iron
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.495
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Clinical Chemistry / Iron
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.495
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.526
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Magnesium
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.332
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Clinical Chemistry / Total cholesterol
|
HET
|
3f:2m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Total cholesterol
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / Total cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00406
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0782
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Clinical Chemistry / Total cholesterol
|
HET
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.101
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total cholesterol
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.131
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Total cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.171
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Clinical Chemistry / Total cholesterol
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.223
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Total cholesterol
|
HET
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.499
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Total cholesterol
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.556
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.591
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Clinical Chemistry / Total cholesterol
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.597
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Total cholesterol
|
HET
|
6f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.719
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total cholesterol
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.839
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Total protein
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Clinical Chemistry / Total protein
|
HET
|
3f:1m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total protein
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00802
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0346
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Clinical Chemistry / Total protein
|
HET
|
5f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0884
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Clinical Chemistry / Total protein
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.141
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Total protein
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.190
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Clinical Chemistry / Total protein
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.310
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total protein
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.350
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / Total protein
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.516
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total protein
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.647
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Total protein
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.669
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Total protein
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.762
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Total protein
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.764
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Clinical Chemistry / Cholesterol ratio
|
HET
|
1f:1m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Cholesterol ratio
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0575
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / Cholesterol ratio
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0686
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Cholesterol ratio
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.360
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Clinical Chemistry / Cholesterol ratio
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.465
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Clinical Chemistry / Cholesterol ratio
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.571
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Cholesterol ratio
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.725
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Clinical Chemistry / Cholesterol ratio
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.807
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0966
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0984
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.126
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.208
|
Successful |
Nxnem1(IMPC)J
|
JAX
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.270
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.288
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.400
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.624
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.700
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.792
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
8f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.892
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.936
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.997
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Plasma Chemistry / HDL cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.471
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Clinical Chemistry / Albumin
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Albumin
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.00749
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / Albumin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.196
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Clinical Chemistry / Albumin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.236
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Albumin
|
HET
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.485
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Albumin
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.590
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Albumin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.635
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Clinical Chemistry / Albumin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.657
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Albumin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.665
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Albumin
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.677
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Clinical Chemistry / Albumin
|
HET
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.817
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Albumin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.876
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Albumin
|
HET
|
6f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.978
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Gross Morphology Embryo E18.5 / Cyanosis
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Gross Morphology Embryo E18.5 / Cyanosis
|
HOM
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Gross Morphology Embryo E18.5 / Cyanosis
|
HET
|
8f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Gross Morphology Embryo E18.5 / Cyanosis
|
HOM
|
13f:5m
|
Supplied as data
|
1.00
|
Successful |
Nxnem1(IMPC)J
|
JAX
|
Gross Morphology Embryo E18.5 / Cyanosis
|
HOM
|
1f:7m
|
Supplied as data
|
1.00
|
Successful |
Nxnem1(IMPC)J
|
JAX
|
Gross Morphology Embryo E18.5 / Cyanosis
|
HET
|
6f:10m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Gross Morphology Embryo E18.5 / Cyanosis
|
HET
|
10f:9m
|
Supplied as data
|
1.00
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Gross Morphology Embryo E18.5 / Cyanosis
|
HOM
|
8f:5m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Gross Morphology Embryo E18.5 / Cyanosis
|
HOM
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000416
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000641
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0529
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0922
|
Successful |
Nxnem1(IMPC)J
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0997
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.105
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.139
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.170
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.247
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.261
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
8f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.527
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.596
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.736
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.906
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / UIBC (unsaturated iron binding capacity)
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.158
|
Successful |
Nxnem1(IMPC)J
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
7.74×10-06
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0405
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.176
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.181
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.191
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
4f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.287
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.321
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.337
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.491
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.655
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.660
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
8f:9m
|
Linear Mixed Model framework, LME, not including Weight
|
0.761
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.833
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.888
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.905
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Clinical Chemistry / Total bilirubin
|
HET
|
3f:1m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Total bilirubin
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / Total bilirubin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00515
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Total bilirubin
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0123
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Clinical Chemistry / Total bilirubin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0230
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total bilirubin
|
HET
|
9f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.116
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Clinical Chemistry / Total bilirubin
|
HET
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.125
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Total bilirubin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.194
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Clinical Chemistry / Total bilirubin
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.222
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Total bilirubin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.520
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Total bilirubin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.755
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Total bilirubin
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.918
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.976
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Total bilirubin
|
HET
|
6f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.999
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0216
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.121
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.231
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
6f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.252
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.290
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.301
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.462
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.621
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.623
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.756
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.828
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.968
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.178
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / LDL-cholesterol
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.198
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acids
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0555
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Clinical Chemistry / Free fatty acids
|
HET
|
3f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.865
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
756f:672m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
f:2903m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
350f:350m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
f:210m
|
|
|
NotProcessed |
Nxnem1(IMPC)Bay
|
BCM
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
353f:356m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
147f:147m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
f:556m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
350f:350m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
170f:165m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
410f:473m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat production (metabolic rate)
|
HET
|
f:143m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total cholesterol
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total cholesterol
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total cholesterol
|
HET
|
5f:5m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Triglyceride
|
HET
|
5f:5m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Triglyceride
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Triglyceride
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Clinical Chemistry / Calcium
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Calcium
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Clinical Chemistry / Calcium
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0545
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Calcium
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.153
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Calcium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.181
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Clinical Chemistry / Calcium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.189
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Calcium
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.375
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / Calcium
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.407
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Clinical Chemistry / Calcium
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.491
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Calcium
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.633
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Calcium
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.643
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Calcium
|
HET
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.650
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.659
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Calcium
|
HET
|
6f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.954
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Clinical Chemistry / Glucose
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Glucose
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Glucose
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0426
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Glucose
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.290
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Glucose
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.318
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Clinical Chemistry / Glucose
|
HET
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.387
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.516
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Clinical Chemistry / Glucose
|
HET
|
2f:4m
|
Linear Mixed Model framework, LME, including Weight
|
0.589
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / Glucose
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.623
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Glucose
|
HET
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.672
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Clinical Chemistry / Glucose
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.710
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Glucose
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.717
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Glucose
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.813
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Glucose
|
HET
|
6f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.845
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Challenge Whole Body Plethysmography / Enhanced pause (Penh)
|
HET
|
394f:383m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Sodium
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Sodium
|
HET
|
8f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Sodium
|
HET
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00792
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / Sodium
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0154
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Sodium
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.115
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Clinical Chemistry / Sodium
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.190
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Sodium
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.445
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Clinical Chemistry / Sodium
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.458
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.750
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Echo / Body Temp
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.101
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Echo / Body Temp
|
HET
|
6f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.102
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Echo / Body Temp
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.357
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0342
|
Successful |
Nxnem1(IMPC)J
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000199
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00551
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
8f:9m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0317
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0719
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.132
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.350
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.391
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.602
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.669
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.674
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.863
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.944
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.955
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.977
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Creatine kinase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.473
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Creatine kinase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.588
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.632
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
147f:147m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
f:143m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
f:210m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
410f:473m
|
|
|
NotProcessed |
Nxnem1(IMPC)Bay
|
BCM
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
353f:356m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
756f:672m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
f:2903m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
350f:350m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
350f:350m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
170f:165m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Indirect Calorimetry / Oxygen consumption
|
HET
|
f:556m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Potassium
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / Potassium
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00140
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Potassium
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.229
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Clinical Chemistry / Potassium
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.257
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Potassium
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.363
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Potassium
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.552
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Clinical Chemistry / Potassium
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.782
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.913
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Potassium
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.996
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0310
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
8f:9m
|
Linear Mixed Model framework, LME, including Weight
|
0.0395
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0438
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0732
|
Successful |
Nxnem1(IMPC)J
|
JAX
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.208
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.289
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.349
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.399
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.400
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.429
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.457
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.546
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.608
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Clinical Chemistry / Phosphorus
|
HET
|
3f:2m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Phosphorus
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Phosphorus
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0311
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Phosphorus
|
HET
|
6f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.114
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Phosphorus
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.126
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Clinical Chemistry / Phosphorus
|
HET
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.141
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / Phosphorus
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.191
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Phosphorus
|
HET
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.265
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Clinical Chemistry / Phosphorus
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.339
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Phosphorus
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.568
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Phosphorus
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.654
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Phosphorus
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.820
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Clinical Chemistry / Phosphorus
|
HET
|
5f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.832
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.921
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Chloride
|
HET
|
5f:5m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Chloride
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Chloride
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total protein
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total protein
|
HET
|
5f:5m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Total protein
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
1f:1m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
3.57×10-05
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0237
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0509
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0856
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.227
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.465
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.655
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.809
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
8f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.960
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.967
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Albumin
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Albumin
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Albumin
|
HET
|
5f:5m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Uric acid
|
HET
|
7f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.479
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Calcium
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Calcium
|
HET
|
5f:5m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Calcium
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Thyroxine
|
HET
|
4f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.925
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Chloride
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Chloride
|
HET
|
8f:8m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Chloride
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.00855
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Clinical Chemistry / Chloride
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0105
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / Chloride
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0458
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Chloride
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0497
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Clinical Chemistry / Chloride
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.219
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Chloride
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.362
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.690
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Insulin Blood Level / Insulin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.144
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Insulin Blood Level / Insulin
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.155
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Insulin Blood Level / Insulin
|
HET
|
4f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.528
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Insulin Blood Level / Insulin
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.551
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Insulin Blood Level / Insulin
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.792
|
Successful |
Nxnem1(IMPC)J
|
JAX
|
Gross Morphology Embryo E12.5 / Edema
|
HOM
|
5f:2m
|
Supplied as data
|
1.00
|
Successful |
Nxnem1(IMPC)J
|
JAX
|
Gross Morphology Embryo E12.5 / Edema
|
HET
|
7f:13m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Gross Morphology Embryo E12.5 / Edema
|
HOM
|
3f:m
|
Supplied as data
|
1.00
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Gross Morphology Embryo E12.5 / Edema
|
HOM
|
4f:2m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Gross Morphology Embryo E12.5 / Edema
|
HET
|
17f:10m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Gross Morphology Embryo E12.5 / Edema
|
HOM
|
3f:4m
|
Supplied as data
|
1.00
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Gross Morphology Embryo E12.5 / Edema
|
HET
|
11f:8m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Gross Morphology Embryo E12.5 / Edema
|
HOM
|
8f:4m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Gross Morphology Embryo E12.5 / Edema
|
HET
|
5f:6m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Gross Morphology Embryo E12.5 / Edema
|
HET
|
3f:11m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Plasma Chemistry / Free fatty acids
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.677
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
35f:35m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
40f:40m
|
|
|
NotProcessed |
Nxnem1(IMPC)Bay
|
BCM
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
40f:40m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
35f:35m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
4f:7m
|
|
|
NotProcessed |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
40f:40m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
40f:35m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
40f:40m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
40f:40m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
35f:35m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
45f:40m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
40f:40m
|
|
|
NotProcessed |
Nxnem1(IMPC)J
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
40f:35m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
40f:45m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
40f:40m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Phosphorus
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Phosphorus
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Phosphorus
|
HET
|
5f:5m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Iron
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Iron
|
HET
|
5f:5m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Iron
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
5f:5m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
5f:5m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Glycosilated hemoglobin A1c (HbA1c)
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.863
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
5f:5m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
5f:5m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.508
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / Lactate dehydrogenase
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.813
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00208
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0290
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0453
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0490
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0999
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.255
|
Successful |
Nxnem1(IMPC)Bay
|
BCM
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.378
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
f:11m
|
Linear Mixed Model framework, LME, not including Weight
|
0.445
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.547
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.662
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Indirect Calorimetry / Respiratory Exchange Ratio
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.948
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
756f:672m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
147f:147m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
f:556m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
f:2903m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
350f:350m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
f:210m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
f:143m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
350f:350m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
170f:165m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
410f:473m
|
|
|
NotProcessed |
Nxnem1(IMPC)Bay
|
BCM
|
Indirect Calorimetry / Carbon dioxide production
|
HET
|
353f:356m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alpha-amylase
|
HET
|
2f:m
|
|
|
NotProcessed |
Nxntm1a(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Alpha-amylase
|
HET
|
5f:5m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Gross Morphology Embryo E14.5-E15.5 / Edema
|
HOM
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Gross Morphology Embryo E14.5-E15.5 / Edema
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Gross Morphology Embryo E14.5-E15.5 / Edema
|
HET
|
4f:8m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Gross Morphology Embryo E14.5-E15.5 / Edema
|
HET
|
12f:13m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Gross Morphology Embryo E14.5-E15.5 / Edema
|
HOM
|
5f:3m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Gross Morphology Embryo E14.5-E15.5 / Edema
|
HOM
|
11f:4m
|
Supplied as data
|
1.00
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Triglycerides
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Clinical Chemistry / Triglycerides
|
HET
|
3f:1m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Clinical Chemistry / Triglycerides
|
HET
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00439
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglycerides
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0795
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Clinical Chemistry / Triglycerides
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.0833
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Triglycerides
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.129
|
Successful |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Triglycerides
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.203
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Triglycerides
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.451
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Clinical Chemistry / Triglycerides
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.535
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / Triglycerides
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
8.46×10-05
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Triglycerides
|
HET
|
7f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.836
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Triglycerides
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.867
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Triglycerides
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.907
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Triglycerides
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.981
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Plasma Chemistry / Glucose
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.815
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
1f:m
|
|
|
NotProcessed |
Nxntm1b(EUCOMM)Wtsi
|
UC Davis
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Nxnem1(IMPC)Mbp
|
UC Davis
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0138
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
TCP
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
8f:7m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0180
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
7f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0458
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
HMGU
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
9f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.125
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MRC Harwell
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.158
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
MARC
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.180
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
CCP-IMG
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
8f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.181
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.263
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
JAX
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
5f:6m
|
Linear Mixed Model framework, LME, including Weight
|
0.350
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
RBRC
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.434
|
Successful |
Nxntm1b(EUCOMM)Wtsi
|
ICS
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.438
|
Successful |
Nxntm1a(EUCOMM)Wtsi
|
BCM
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
6f:6m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.819
|
Successful |